SINGAPORE: The Ministry of Health (MOH) will subsidise the cost of shingles vaccine Shingrix for eligible Singaporeans and permanent residents, who may also use MediSave to pay for the jabs.
SINGAPORE – Shingles vaccine Shingrix will soon be made more affordable for eligible Singaporeans and permanent residents (PRs). From September 2025, they can enjoy means-tested subsidies of up ...
GlaxoSmithKline places its shingles vaccine Shingrix among its top prospects, with peak sales potential of almost $6 billion. Now, Pfizer and BioNTech are joining forces to try to grab a slice of ...
SINGAPORE: The Ministry of Health (MOH) announced on Monday (Feb 10) that it will extend subsidies and MediSave usage for Shingrix, the shingles vaccine, for eligible Singaporeans and permanent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback